M
Matthew S. Miller
Researcher at McMaster University
Publications - 102
Citations - 3941
Matthew S. Miller is an academic researcher from McMaster University. The author has contributed to research in topics: Medicine & Virus. The author has an hindex of 25, co-authored 77 publications receiving 2569 citations. Previous affiliations of Matthew S. Miller include McMaster-Carr & Icahn School of Medicine at Mount Sinai.
Papers
More filters
Journal ArticleDOI
Reporting and evaluating influenza virus surveillance data: An argument for incidence by single year of age.
Journal ArticleDOI
Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes
Vidthiya Jeyanathan,Sam Afkhami,Michael F. D'Agostino,Anna Zganiacz,Xueya Feng,Matthew S. Miller,Mangalakumari Jeyanathan,Michael R. Thompson,Zhou Xing +8 more
TL;DR: Compared to intranasal delivery, the deepened and widened biodistribution in the lung following endotracheal delivery is associated with much improved vaccine-mediated immunogenicity and protection against the target pathogen.
Journal ArticleDOI
Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study
Sergey Yegorov,Irina Kadyrova,Baurzhan Negmetzhanov,Yevgeniya Kolesnikova,S. Kolesnichenko,Ilya Korshukov,Yeldar Baiken,Bakhyt T. Matkarimov,Matthew S. Miller,Gonzalo Hortelano,Dmitriy Babenko +10 more
TL;DR: In this paper , the authors performed a prospective cohort study to assess the reactogenicity and immunologic outcomes of Sputnik-V vaccination in Kazakhstan, and found that most of the reported adverse events were mild-to-moderate injection site or systemic reactions, no severe or potentially life-threatening conditions were reported, and dose 1 appeared to be more reactogenic than dose 2.
Journal ArticleDOI
Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections
Allison E. Kennedy,Laura Cook,Jessica A. Breznik,Braeden Cowbrough,Jessica G. Wallace,Angela Huynh,James W. Smith,Kiho Son,Hannah D. Stacey,Jann Ang,Allison McGeer,Brenda L. Coleman,Maggie Larché,Mark Larché,Nathan Hambly,Parameswaran Nair,Kjetil Ask,Matthew S. Miller,Jonathan L. Bramson,Megan K. Levings,Ishac Nazy,Sarah Svenningsen,Manali Mukherjee,Dawn M. E. Bowdish +23 more
TL;DR: In this paper, the authors investigated lasting changes to soluble inflammatory factors and cellular immune phenotype and function in individuals who had recovered from mild SARS-CoV-2 infections (n = 22) compared to those that had been previously infected with other mild respiratory infections, and found that significantly more T-cells could be activated by polyclonal stimulation compared to individuals with other recent respiratory infections.
Journal ArticleDOI
High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination
Irina Kadyrova,Sergey Yegorov,Baurzhan Negmetzhanov,Yevgeniya Kolesnikova,S. Kolesnichenko,Ilya Korshukov,Lyudmila Akhmaltdinova,Dmitriy Vazenmiller,Yelena Stupina,Naylya Kabildina,Assem Nurzhankyzy Ashimova,A.A Raimbekova,A. Turmukhambetova,Matthew S. Miller,Gonzalo Hortelano,Dmitriy Babenko +15 more
TL;DR: Overall, SARS-CoV-2 exposure in this cohort was ~15-fold higher compared to the reported all-time national and regional COVID-19 prevalence, consistent with recent studies of excess infection and death in Kazakhstan.